Current status and prospects of plant genome editing in Australia

被引:11
|
作者
Zhang, Yan [1 ,2 ]
Restall, Jemma [1 ]
Crisp, Peter [2 ]
Godwin, Ian [1 ]
Liu, Guoquan [1 ]
机构
[1] Univ Queensland, Ctr Crop Sci, Queensland Alliance Agr & Food Innovat, Brisbane, Qld 4072, Australia
[2] Univ Queensland, Sch Agr & Food Sci, Brisbane, Qld 4072, Australia
基金
澳大利亚研究理事会;
关键词
Plant genome editing; Australia; CRISPR-Cas; Transgene-free; Regulation; GMO; NICOTIANA-BENTHAMIANA; SORGHUM; CRISPR/CAS9; MUTAGENESIS; SYSTEM; GENES;
D O I
10.1007/s11627-021-10188-y
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Plant genome editing, particularly CRISPR-Cas biotechnologies, has rapidly evolved and drawn enormous attention all around the world in the last decade. The cutting-edge technologies have had substantial impact on precise genome editing for manipulating gene expression, stacking gene mutations, and improving crop agronomic traits. Following the global trends, investigations on CRISPR-Cas have been thriving in Australia, especially in agriculture sciences. Importantly, CRISPR-edited plants, classified as SDN-1 organisms (SDN: site-directed nuclease), have been given a green light in Australia, with regulatory bodies indicating they will not be classified as a genetically modified organism (GMO) if no foreign DNA is present in an edited plant. As a result, genome-edited products would not attract the onerous regulation required for the introduction of a GMO, which could mean more rapid deployment of new varieties and products that could be traded freely in Australia, and potentially to export markets. In the present review, we discuss the current status and prospects of plant genome editing in Australia by highlighting several species of interest. Using these species as case studies, we discuss the priorities and potential of plant genome editing, as well as the remaining challenges.
引用
收藏
页码:574 / 583
页数:10
相关论文
共 50 条
  • [41] CRISPR/Cas9 for plant genome editing: accomplishments, problems and prospects
    Joseph W. Paul
    Yiping Qi
    [J]. Plant Cell Reports, 2016, 35 : 1417 - 1427
  • [42] Precision Genome Editing Techniques in Gene Therapy: Current State and Future Prospects
    Singh, Kuldeep
    Bhushan, Bharat
    Kumar, Sunil
    Singh, Supriya
    Macadangdang Jr, Romulo R.
    Pandey, Ekta
    Varma, Ajit Kumar
    Kumar, Shivendra
    [J]. CURRENT GENE THERAPY, 2024, 24 (05) : 377 - 394
  • [43] Current status of the sequence of the rice genome and prospects for finishing the first monocot genome
    Buell, CR
    [J]. PLANT PHYSIOLOGY, 2002, 130 (04) : 1585 - 1586
  • [44] Therapeutic genome editing: prospects and challenges
    David Benjamin Turitz Cox
    Randall Jeffrey Platt
    Feng Zhang
    [J]. Nature Medicine, 2015, 21 : 121 - 131
  • [45] Therapeutic genome editing: prospects and challenges
    Cox, David Benjamin Turitz
    Platt, Randall Jeffrey
    Zhang, Feng
    [J]. NATURE MEDICINE, 2015, 21 (02) : 121 - 131
  • [46] Trends and prospects in mitochondrial genome editing
    Phan, Hong Thi Lam
    Lee, Hyunji
    Kim, Kyoungmi
    [J]. EXPERIMENTAL AND MOLECULAR MEDICINE, 2023, 55 (05): : 871 - 878
  • [47] Trends and prospects in mitochondrial genome editing
    Hong Thi Lam Phan
    Hyunji Lee
    Kyoungmi Kim
    [J]. Experimental & Molecular Medicine, 2023, 55 : 871 - 878
  • [48] Embryonic Regulation and Research: What Is the Status of Human Germline Genome Editing in Australia?
    Burbery, Rose
    [J]. JOURNAL OF LAW AND MEDICINE, 2020, 27 (03) : 718 - 740
  • [49] Human genome project: Current status, Keio strategy, and prospects
    Shimizu, N
    [J]. NEURAL DEVELOPMENT-BOOK, 1999, 2 : 535 - 540
  • [50] Genome engineering in ornamental plants: Current status and future prospects
    Kishi-Kaboshi, Mitsuko
    Aida, Ryutaro
    Sasaki, Katsutomo
    [J]. PLANT PHYSIOLOGY AND BIOCHEMISTRY, 2018, 131 : 47 - 52